Date published: 2026-4-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

Nevirapine-d4 (CAS 1051418-95-1)

0.0(0)
Write a reviewAsk a question

Alternate Names:
11-(cyclopropyl-2,2,3,3-d4)-4-methyl-5,11-dihydro-6H-dipyrido[3,2-b:2′,3′-e][1,4]diazepin-6-one
Application:
Nevirapine-d4 is a selective non-nucleoside inhibitor of HIV-1 reverse transcriptase
CAS Number:
1051418-95-1
Molecular Weight:
270.33
Molecular Formula:
C15H9D4N4O
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

Nevirapine-d4 is a deuterated form of nevirapine, where four hydrogen atoms are replaced with deuterium. This isotopic substitution is primarily used in research to facilitate the detailed study of the compound′s properties using analytical techniques such as mass spectrometry and nuclear magnetic resonance (NMR) spectroscopy. The incorporation of deuterium atoms improves the analytical distinction between nevirapine and its metabolites or degradation products. Nevirapine, and thus nevirapine-d4, acts as a non-nucleoside reverse transcriptase inhibitor (NNRTI). It binds to a specific pocket of the reverse transcriptase enzyme in viruses, distinct from the active site that nucleoside analogs target. This binding induces a conformational change in the enzyme that significantly reduces its activity, effectively inhibiting the viral replication process. The deuterated version, nevirapine-d4, retains this mechanism of action, allowing researchers to study the enzyme-inhibitor interaction in greater detail. In research, nevirapine-d4 is used extensively to understand the dynamics of how this molecule interacts with the reverse transcriptase enzyme. By using the deuterated compound, scientists can track and analyze the metabolic pathways and breakdown of nevirapine more precisely. This is crucial for understanding how the molecule behaves in different environments and for studying its stability under various conditions. Additionally, nevirapine-d4 is valuable in the study of enzyme kinetics. The deuterated atoms can provide insights into the rate of binding and dissociation of the inhibitor from the enzyme, helping to map out the kinetic profile of these interactions. In molecular biology, nevirapine-d4 serves as a tool to investigate the broader implications of reverse transcriptase inhibition on the viral life cycle. By examining how the modified enzyme affects the synthesis of viral DNA, researchers can gain a deeper understanding of the strategies viruses use to replicate and how these can be disrupted.


Nevirapine-d4 (CAS 1051418-95-1) References

  1. Monotypic low-level HIV viremias during antiretroviral therapy are associated with disproportionate production of X4 virions and systemic immune activation.  |  Bull, ME., et al. 2018. AIDS. 32: 1389-1401. PMID: 29683841
  2. Nevirapine plasma concentration is associated with virologic failure and the emergence of drug-resistant mutations among HIV patients in Kenya: A cross sectional study.  |  Omondi, EO., et al. 2022. Medicine (Baltimore). 101: e32346. PMID: 36550885
  3. A LC–MS/MS method with column coupling technique for simultaneous estimation of lamivudine, zidovudine, and nevirapine in human plasma[J].  |  Reddy S, Thomas L, Santoshkumar K S. 2016,. Journal of Analytical Science and Technology,. 7: 1-10.

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

Nevirapine-d4, 1 mg

sc-219352
1 mg
$354.00